Posted by Michael Wonder on 03 Jun 2019
Chinese policies fail to curb soaring drug prices
2 June 2019 - Power of pharmaceutical monopoly starts with the manufacturing of ingredients.
A report by a Mainland local newspaper published on Friday described the phenomenon of rising drug prices in recent years, and the reasons why more than 30 price control strategies by the Chinese government in the last two decades have failed to bring the prices down.
An undercover reporter from the Legal Daily learned from a hospital in Hunan, a mountainous province in southern China, that prices for critical and life-saving drugs including those for resuscitation, blood-clot promoting or boosting white blood cells in patients on chemotherapy, are 10 times higher than last year, the Papercn.com reported.
